AGO2 is the catalytically active member of the Argonaute family and serves as the core component of the RNA-induced silencing complex (RISC) 1. Primary function: AGO2 mediates post-transcriptional gene silencing through miRNA and siRNA-guided mRNA cleavage and translational repression 2. Mechanistically, AGO2 contains four functional domains (N, PAZ, MID, and PIWI) that enable target RNA recognition and catalytic slicing 3. The N domain rotates to allow RNA access to the central channel, while a conserved PIWI loop secures RNA near the active site to enhance slicing rate and specificity 3. AGO2 localizes to both cytoplasm and nucleus, where it assembles into P-bodies through liquid-liquid phase separation interactions with YTHDF1 4. Nuclear AGO2 can activate transcription of genes like ANKRD1, promoting myocardial remodeling in heart failure 5. Beyond canonical silencing, AGO2 regulates alternative polyadenylation, transposon repression, chr8 remodeling, and double-strand break repair 2. Disease relevance: Mutations in AGO2 cause Lessel-Kreienkamp syndrome. AGO2 is upregulated in failing hearts and contributes to cardiac dysfunction 5. Clinical significance: AGO2 is central to RNA interference-based therapeuties. Understanding AGO2 structural dynamics 3 and proper tagging approaches 6 is essential for reliable RISC biology research and therapeutic development.